Denosumab in men receiving androgen-deprivation therapy for prostate cancer

Smith, MR; Egerdie, B; Hernández Toriz, N; Feldman, R; Tammela, TL; Saad, F; Heracek, J; Szwedowski, M; Ke, C; Kupic, A; Leder, BZ; Goessl, C; Denosumab, HALT Prostate Cancer Study Group (2009). Denosumab in men receiving androgen-deprivation therapy for prostate cancer. New England journal of medicine NEJM, 361(8), pp. 745-755. Waltham, Mass.: Massachusetts Medical Society MMS 10.1056/NEJMoa0809003

Full text not available from this repository. (Request a copy)

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Orthopaedic, Plastic and Hand Surgery (DOPH) > Clinic of Osteoporosis

UniBE Contributor:

Lippuner, Kurt

ISSN:

0028-4793

Publisher:

Massachusetts Medical Society MMS

Language:

English

Submitter:

Factscience Import

Date Deposited:

04 Oct 2013 15:13

Last Modified:

05 Dec 2022 14:22

Publisher DOI:

10.1056/NEJMoa0809003

Web of Science ID:

000269081200003

URI:

https://boris.unibe.ch/id/eprint/32399 (FactScience: 197556)

Actions (login required)

Edit item Edit item
Provide Feedback